The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...
Health and Me on MSN
Can CRISPR cure HIV? Scientists say virus removed from cells in new research
Scientists are testing CRISPR gene editing as a potential HIV cure after successfully removing the virus from infected cells ...
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
News Medical on MSN
Immune dysfunction persists after combined TB and HIV therapy
The immune system remains seriously out-of-whack – in an inflammatory state of overactivation and impaired functionality – ...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Distinct patterns of SARS-CoV-2 viral dynamics in saliva reveal heterogeneity that cannot be sufficiently explained by conventional clinical characteristics or microRNA profiles alone.
This study systematically elucidates the drug resistance mechanisms of five highly pathogenic viruses, proposes five innovative anti-resistance strategies, and integrates artificial intelligence ...
Atea continues to advance its global Phase 3 program evaluating the fixed-dose combination (FDC) of BEM, a nucleotide analog ...
Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
Gilead Sciences Inc. (NASDAQ:GILD) is one of the best stocks for the next decade. On December 12, Morgan Stanley raised the firm’s price target on Gilead to $151 from $147 with an Overweight rating on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback